Skip to main content
Log in

Controlled Cell Death by Magnetic Hyperthermia: Effects of Exposure Time, Field Amplitude, and Nanoparticle Concentration

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

To investigate the effects of alternating magnetic fields (AMF) on the death rate of dendritic cells (DCs) loaded with magnetic nanoparticles (MNPs) as heating agents. AMF exposure time and amplitude as well as the MNPs concentration were screened to assess the best conditions for a controlled field-induced cell death.

Methods

Human-monocyte-derived DCs were co-incubated with dextran-coated MNPs. The cells were exposed to AMF (f = 260 kHz; 0 < H0 < 12.7 kA/m) for intervals from 5 to 15 min. Morphology changes were assessed by scanning electron microscopy. Cell viability was measured by Trypan blue and fluorescence-activated cell sorting (FACS) using Annexin-propidium iodide markers.

Results

We were able to control the DCs viability by a proper choice AMF amplitude and exposure time, depending on the amount of MNPs uploaded. About 20% of cells showed Annexin-negative/PI-positive staining after 5–10 min of AMF exposure.

Conclusions

Controlled cell death of MNP-loaded DCs can be obtained by adequate tuning of the physical AMF parameters and MNPs concentration. Necrotic-like populations were observed after exposure times as short as 10 min, suggesting a fast underlying mechanism for cell death. Power absorption by the MNPs might locally disrupt endosomic membranes, thus provoking irreversible cell damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

REFERENCES

  1. Woodhall B, Pickrell KL, Georgiade NG, Mahaley MS, Dukes HT. Effect of hyperthermia upon cancer chemotherapy - Application to external cancers of head and face structures. Ann Surg. 1960;151:750–9.

    Article  PubMed  CAS  Google Scholar 

  2. Turnbull AR. Hyperthermia and cancer. Lancet. 1975;1:643–4.

    Article  PubMed  CAS  Google Scholar 

  3. de Bree E, Theodoropoulos PA, Rosing H, Michalakis J, Romanos J, Beijnen JH, et al. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From laboratory bench to bedside. Cancer Treat Rev. 2006;32:471–82.

    Article  PubMed  Google Scholar 

  4. Storm FK, Elliott RS, Harrison WH, Morton DL. Clinical rf hyperthermia by magnetic-loop induction - A new approach to human cancer-therapy. IEEE Trans Microw Theory Tech. 1982;30:1149–57.

    Article  Google Scholar 

  5. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids - Physical evaluation of their potential for Hyperthermia. Int J Hyperthermia. 1993;9:51–68.

    Article  PubMed  CAS  Google Scholar 

  6. Magforce. “Magforce nanotechnologies ag receives european regulatory approval for its Nanocancer® therapy.” 2010.

  7. Matsuda H, Tsutsui S, Morita M, Baba K, Kitamura K, Kuwano H, et al. Hyperthermo-chemo-radiotherapy as a definitive treatment for patients with early esophageal-carcinoma. Am J Clin Oncol-Cancer Clin Trials. 1992;15:509–14.

    CAS  Google Scholar 

  8. Nie SM. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine. 2010;5:523–8.

    Article  PubMed  Google Scholar 

  9. Marcos-Campos I, Asin L, Torres TE, Marquina C, Tres A, Ibarra MR, et al. Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells. Nanotechnology. 2011;22:13.

    Article  Google Scholar 

  10. Banchereauand J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–52.

    Article  Google Scholar 

  11. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 2002;20:621–67.

    Article  PubMed  CAS  Google Scholar 

  12. Trombettaand ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975–1028.

    Article  Google Scholar 

  13. Bodey B, Siegel SE, Kaiser HE. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy. In Vivo. 2004;18:81–100.

    PubMed  CAS  Google Scholar 

  14. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 2002;298:1025–9.

    Article  PubMed  CAS  Google Scholar 

  15. Andersson LIM, Hellman P, Eriksson H. Receptor-mediated endocytosis of particles by peripheral dendritic cells. Hum Immunol. 2008;69:625–33.

    Article  PubMed  CAS  Google Scholar 

  16. Molavi L, Mahmud A, Hamdy S, Hung RW, Lai R, Samuel J, et al. Development of a Poly(D, L-lactic-co-glycolic acid) Nanoparticle Formulation of STAT3 Inhibitor JSI-124: Implication for Cancer Immunotherapy. Mol Pharm. 2010;7:364–74.

    Article  PubMed  CAS  Google Scholar 

  17. Basic specifications from the provider includes: Hydrodynamic size: 250 nm; NP concentration:10 mg/ml (4.9x1011 MNPs/ml); Polydispersity index < 0.2; MS (H = 1 T) = 67 emu/g., 2009.

  18. Martin-Saavedra FM, Ruiz-Hernandez E, Bore A, Arcos D, Vallet-Regi M, Vilaboa N. Magnetic mesoporous silica spheres for hyperthermia therapy. Acta Biomaterialia. 2010;6:4522–4531.

    Google Scholar 

  19. Fortin JP, Gazeau F, Wilhelm C. Intracellular heating of living cells through Neel relaxation of magnetic nanoparticles. Eur Biophys J Biophys Lett. 2008;37:223–8.

    Article  CAS  Google Scholar 

  20. Rodriguez-Luccioni HL, Latorre-Esteves M, Mendez-Vega J, Soto O, Rodriguez AR, Rinaldi C, et al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int J Nanomed. 2011;6:373–380.

    Google Scholar 

  21. Duguet E, Hardel L, Vasseur S. Cell targeting and magnetically induced hyperthermia. Thermal nanosystems and nanomaterials, vol. 118. Berlin: Springer-Verlag Berlin; 2009. p. 343–65.

    Google Scholar 

  22. Prasad NK, Rathinasamy K, Panda D, Bahadur D. Mechanism of cell death induced by magnetic hyperthermia with nanoparticles of gamma-MnxFe2-xO3 synthesized by a single step process. J Mater Chem. 2007;17:5042–51.

    Article  CAS  Google Scholar 

  23. Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int J Hyperthermia. 2002;18:194–202.

    Article  PubMed  CAS  Google Scholar 

  24. Villanueva A, de la Presa P, Alonso JM, Rueda T, Martinez A, Crespo P, et al. Hyperthermia HeLa Cell Treatment with Silica-Coated Manganese Oxide Nanoparticles. J Phys Chem C. 2010;114:1976–81.

    Article  CAS  Google Scholar 

  25. Creixell M, Bohorquez AC, Torres-Lugo M, Rinaldi C. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano. 2011;5:7124–7129.

    Google Scholar 

  26. Lunov O, Zablotskii V, Pastor JM, Perez-Landazabal JI, Gomez-Polo C, Syrovets T, et al. Thermal Destruction on the Nanoscale: Cell Membrane Hyperthermia with Functionalized Magnetic Nanoparticles. In: Hafeli U, Schutt W, Zborowski M, editors. 8th Internatioanl Conference on the Scientific and Clinical Applications of Magnetic Carriers, Vol. 1311, Amer Inst Physics, Melville, 2010, pp. 288–292.

  27. Beaune G, Levy M, Neveu S, Gazeau F, Wilhelm C, Menager C. Different localizations of hydrophobic magnetic nanoparticles within vesicles trigger their efficiency as magnetic nano-heaters. Soft Matter. 2011;7:6248–54.

    Article  CAS  Google Scholar 

Download references

Acknowledgments & Disclosures

This work was supported by the Spanish Ministerio de Ciencia e Innovación (project MICINN MAT2010-19326 and CONSOLIDER NANOBIOMED CS-27 2006) and IBERCAJA. LA acknowledges MICINN by financial support through a FPU fellowship. The University of Zaragoza, along with their researchers, have filled patents related to the technology and intellectual property reported here. G.F.G. and M.R. I. have equity in nB Nanoscale Biomagnetics S.L. The other authors declare that they do not have any affiliations that would lead to conflict of interest. We are grateful to the I + CS staff (University Hospital, Zaragoza) Dr. J. Godino (FACS experiments) and Dr. M. Royo Cañas (confocal microscopy) for their advice and technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. F. Goya.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 1215 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asín, L., Ibarra, M.R., Tres, A. et al. Controlled Cell Death by Magnetic Hyperthermia: Effects of Exposure Time, Field Amplitude, and Nanoparticle Concentration. Pharm Res 29, 1319–1327 (2012). https://doi.org/10.1007/s11095-012-0710-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-012-0710-z

KEY WORDS

Navigation